These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9087973)

  • 21. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine modulates aromatic L-amino acid decarboxylase activity in mouse striatum.
    Neff NH; Wemlinger TA; Duchemin AM; Hadjiconstantinou M
    J Pharmacol Exp Ther; 2006 May; 317(2):480-7. PubMed ID: 16415089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
    Zhang K; Davids E; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Apr; 161(1):100-6. PubMed ID: 11967637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I; Kehr J; Andbjer B; Fuxe K
    Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.
    Burstein ES; Ma J; Wong S; Gao Y; Pham E; Knapp AE; Nash NR; Olsson R; Davis RE; Hacksell U; Weiner DM; Brann MR
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1278-87. PubMed ID: 16135699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics.
    Gioanni Y; Thierry AM; Glowinski J; Tassin JP
    Synapse; 1998 Dec; 30(4):362-70. PubMed ID: 9826228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C; Abraini JH; David HN
    Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys.
    Kanda T; Jackson MJ; Smith LA; Pearce RK; Nakamura J; Kase H; Kuwana Y; Jenner P
    Exp Neurol; 2000 Apr; 162(2):321-7. PubMed ID: 10739638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Atypical neuroleptics, pharmacology and clinical importance].
    Klages U; Hippius H; Müller-Spahn F
    Fortschr Neurol Psychiatr; 1993 Nov; 61(11):390-8. PubMed ID: 7903656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General pharmacology of clozapine.
    Coward DM
    Br J Psychiatry Suppl; 1992 May; (17):5-11. PubMed ID: 1358127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism.
    Seeman P; Corbett R; Nam D; Van Tol HH
    Jpn J Pharmacol; 1996 Jul; 71(3):187-204. PubMed ID: 8854201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological modifications in dopaminergic neurotransmission affect the quinpirole-evoked suppression of serotonin N-acetyltransferase activity in chick retina: an impact on dopamine D4-like receptors.
    Zawilska JB; Derbiszewska T; Nowak JZ
    J Neural Transm (Vienna); 1996; 103(12):1405-14. PubMed ID: 9029407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine-induced cognitive dysfunction in mice.
    Ninan I; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1996; 18(6):367-72. PubMed ID: 8892266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biochemistry and pharmacology of benzamides].
    Boyer P
    Sem Hop; 1983 Mar; 59(12):832-5. PubMed ID: 6306780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced movement disorders.
    Gershanik OS
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
    Seeman P; Corbett R; Van Tol HH
    Adv Pharmacol; 1998; 42():478-82. PubMed ID: 9327943
    [No Abstract]   [Full Text] [Related]  

  • 40. The visual system in Parkinson's disease.
    Bodis-Wollner I; Tagliati M
    Adv Neurol; 1993; 60():390-4. PubMed ID: 8420159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.